Patents by Inventor Naina Shah

Naina Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200323948
    Abstract: The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.
    Type: Application
    Filed: April 30, 2020
    Publication date: October 15, 2020
    Inventors: Rajiv JALAN, Naina SHAH
  • Patent number: 10639346
    Abstract: The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: May 5, 2020
    Assignee: Yaqrit Limited
    Inventors: Rajiv Jalan, Naina Shah
  • Publication number: 20180256669
    Abstract: The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.
    Type: Application
    Filed: January 8, 2018
    Publication date: September 13, 2018
    Inventors: Rajiv JALAN, Naina SHAH
  • Patent number: 9889176
    Abstract: The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: February 13, 2018
    Assignee: YAQRIT LIMITED
    Inventors: Rajiv Jalan, Naina Shah
  • Publication number: 20130324471
    Abstract: The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.
    Type: Application
    Filed: August 17, 2011
    Publication date: December 5, 2013
    Inventors: Rajiv Jalan, Naina Shah
  • Patent number: 8252314
    Abstract: This invention is directed generally to compositions (including foods, supplements, treats, toys, etc.) for animal (including pet) consumption, and particularly hypoallergenic compositions, and more particularly semi-solid hypoallergenic compositions and hypoallergenic compositions that comprise a hydrolysate. This invention also is directed generally to methods for using such compositions. This invention is further directed generally to processes for making such compositions.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: August 28, 2012
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Mark Dierking, Dennis Jewell, Luis Montelongo, Fernando Qvyjt, Naina Shah, Timothy Vande Giessen
  • Publication number: 20090054301
    Abstract: This invention is directed generally to compositions (including foods, supplements, treats, toys, etc.) for animal (including pet) consumption, and particularly hypoallergenic compositions, and more particularly semi-solid hypoallergenic compositions and hypoallergenic compositions that comprise a hydrolysate. This invention also is directed generally to methods for using such compositions. This invention is further directed generally to processes for making such compositions.
    Type: Application
    Filed: October 31, 2008
    Publication date: February 26, 2009
    Applicant: Hill's Pet Nutrition, Inc.
    Inventors: Mark Dierking, Dennis Jewell, Luis Montelongo, Fernando Qvyjt, Naina Shah, Timothy Vande Giessen
  • Publication number: 20060067985
    Abstract: This invention is directed generally to compositions (including foods, supplements, treats, toys, etc.) for animal (including pet) consumption, and particularly hypoallergenic compositions, and more particularly semi-solid hypoallergenic compositions and hypoallergenic compositions that comprise a hydrolysate. This invention also is directed generally to methods for using such compositions. This invention is further directed generally to processes for making such compositions.
    Type: Application
    Filed: November 23, 2004
    Publication date: March 30, 2006
    Inventors: Mark Dierking, Dennis Jewell, Luis Montelongo, Fernando Qvyjt, Naina Shah, Timothy Giessen